Welcome To The Stem Cell Therapeutics HUB On AGORACOM
Stem Cell is a public biotechnology company focused on the development and commercialization of drug-based therapies to treat central nervous system diseases.
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Close

Off topic Forum: Stem Cell Therapeutics

New Message
Message Title Rating Author / Date

There are no messages in this forum

New Message

AGORACOM Quick Tips

Small-Cap CEO Lessons - Is Your CEO Out Of Touch? ... Not Anymore
Click To Watch Today's Show

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote

Open SSS:CA Stock Quote

Investment Ideas

Like Stem Cell Therapeutics? Then you might also be interested in Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd.
  • Developer of the TERRASTARTM in-flight safety monitoring system
  • The first system in the world to feature real-time in-flight data monitoring and diagnostics
  • echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS